Osteosarcopenia Training: Muscle Gains, Bone Gap

Resistance training can improve muscle mass and strength in older adults with osteosarcopenia. It has not yet shown a reliable bone-density benefit in this same population. That split matters: osteosarcopenia is failure of both muscle and bone, and treating only one side leaves the central clinical problem half solved.

The best current synthesis pooled seven randomized controlled trials involving 349 older adults with osteosarcopenia. It found statistically significant improvements in skeletal muscle mass index and maximal isometric handgrip strength, while bone mineral density did not improve significantly across the pooled training programs. The 2025 meta-analysis by Hernandez-Martinez et al. therefore supports strength training for muscle, but it does not identify a confirmed minimum effective dose for bone.

Muscle clears the bar; bone has not

That is more useful than the broad claim that "strength training works." It works for outcomes that change relatively quickly: muscle mass, grip strength, and, in some studies, muscle quality. Bone remodeling moves slowly, and the available osteosarcopenia trials are too few to tell us whether bone needs more time, more mechanical specificity, a different form of loading, or simply larger studies.

The individually identifiable ERTO-K randomized trial illustrates the problem. It assigned 34 postmenopausal Korean women with osteosarcopenia to six months of progressive resistance training. The program improved muscle outcomes, but the available abstract does not report bone-density effect sizes. With only 34 participants and a six-month follow-up, the trial cannot settle whether the program affected bone mineral density.

Researchers should resist turning that uncertainty into a prescription with suspiciously exact numbers. The seven-trial meta-analysis did not have enough data for confident dose-response analyses by intensity, frequency, duration, or training volume. At present, no osteosarcopenia-specific trial base establishes that a particular weekly schedule or percentage of one-repetition maximum reliably raises bone mineral density.

What training type seems to help?

Traditional resistance training and elastic-band training both contributed to the muscle and strength findings in the meta-analysis. Elastic-band training showed an advantage for body-fat percentage compared with traditional resistance training, but neither approach produced a significant pooled bone-density result. The body-fat finding does not prove that elastic bands have a special bone effect, and the studies did not test a mechanism for the difference.

The FrOST trial provides a longer look at intensive training. In elderly men with osteosarcopenia, 16 months of high-intensity resistance training significantly reduced thigh muscle fat infiltration, a marker of improved muscle quality. Ghasemikaram et al. reported that result, but the available report does not provide bone-density results for this training phase. It is evidence for muscle quality, not proof that high-intensity resistance training corrected bone loss.

A low-complexity home program looks insufficient for bone. In healthy older adults, the DO-HEALTH randomized trial found minimal areal bone mineral density change with simple home exercise plus vitamin D3 and omega-3 supplementation. This was not an osteosarcopenia trial, so it cannot define treatment in that population. It does show that nutritional co-supplements do not turn a low-specificity exercise program into a dependable bone intervention.

Could low-load blood-flow restriction help bone?

Possibly, but the evidence is adjacent rather than direct. A 2025 meta-analysis in older adults found that low-load blood-flow-restriction training improved bone-health markers without the external loads used in conventional resistance training. Liu et al. challenge the simple idea that only heavy axial loading can produce an osteogenic signal.

That finding should not yet be read as a treatment protocol for osteosarcopenia. The meta-analysis did not specifically study people with established osteosarcopenia, and "bone-health markers" are not automatically the same as a clinically meaningful reduction in fractures. Low-load blood-flow restriction is a reasonable research lead and may matter for people unable to tolerate heavy loading. It still needs direct trials in this phenotype.

Protein helps muscle; the combined muscle-bone dose is unknown

Protein has a better evidence base for the muscle side. A meta-analysis of randomized trials in older adults found that protein interventions amplified resistance-training gains in appendicular lean mass and handgrip strength. Kirwan et al. did not report bone-mineral-density outcomes, so their findings cannot establish a protein dose that improves both muscle and bone.

Protein quality also appears to matter. In adults aged 60 and older, milk protein combined with resistance training reliably increased lean mass in a 2021 meta-analysis. A separate review found higher-biological-value proteins outperformed lower-quality proteins for skeletal-muscle anabolism in young and older adults. Morgan et al. point toward leucine-rich, rapidly digested options such as whey and milk protein when the goal is muscle gain.

A working intake of at least 1.2 g of protein per kilogram of body weight per day is commonly used in sarcopenia discussions, but osteosarcopenia-specific randomized trials have not confirmed that threshold. People with metabolic comorbidities may have greater anabolic resistance, yet no trial in this evidence base quantifies how much additional protein overcomes it. Treat 1.2 g/kg/day as a practical reference point, not a proven combined muscle-and-bone dose.

Calcium has an even clearer evidence gap here. No available osteosarcopenia trial establishes an interaction between calcium intake and resistance training on bone outcomes. Standard bone-health guidance remains sensible, but calcium supplementation cannot substitute for an exercise stimulus capable of changing bone.

Stopping training reverses the gains

The most actionable part of the FrOST evidence may be what happened after training stopped. In a follow-up of 43 older men with osteosarcopenia, participants completed six months without training after the 16-month high-intensity program. Muscle quality deteriorated during detraining; the training group lost about one-third of its intervention-induced muscle-quality gain. The detraining analysis found a statistically significant exercise effect for muscle quality (p = 0.001).

A companion follow-up found substantial reversal of body-composition and cardiometabolic improvements over the same six months. Kemmler et al. do not show that every benefit disappears on the same timetable, but they do show that a finite course of training is a poor model for a chronic condition. Progressive resistance exercise needs to remain part of life.

What to do with the evidence now

• Use progressive resistance training as the foundation for muscle mass, strength, and muscle quality.
• Choose a format that can be performed safely and sustained. Elastic bands are a legitimate option for muscle outcomes; their body-fat advantage does not establish a bone advantage.
• Pair training with adequate high-quality protein, with whey or milk protein as evidence-supported practical options for lean-mass gains in older adults.
• Do not promise that calcium, vitamin D, omega-3s, or protein will compensate for an exercise program that lacks an effective osteogenic stimulus.
• For established osteosarcopenia, discuss individualized loading, fall risk, fracture history, and supervision with a clinician or qualified exercise professional—especially before high-intensity or blood-flow-restriction training.

The honest conclusion is narrow: resistance training reliably improves the muscle component of osteosarcopenia, and the gains fade when training stops. Current osteosarcopenia trials have not yet identified a training dose, protein target, or calcium strategy that reliably improves bone mineral density at the same time.

That gap is not evidence that bone cannot respond. It is evidence that the relevant trials remain small, heterogeneous, and underpowered for a slow-moving endpoint. Until direct studies answer the question, muscle training should be continuous, protein should support that work, and claims that one tidy protocol fixes both compartments should face a high bar.